• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOTRONIK AG, BUELACH, SWITZERLAND ORSIRO 3.0/30; CORONARY DRUG-ELUTING STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOTRONIK AG, BUELACH, SWITZERLAND ORSIRO 3.0/30; CORONARY DRUG-ELUTING STENT Back to Search Results
Model Number 364514
Device Problem Patient Device Interaction Problem (4001)
Patient Problem Thrombosis/Thrombus (4440)
Event Date 04/09/2021
Event Type  Injury  
Manufacturer Narrative
Combination product: yes.
 
Event Description
An orsiro drug-eluting stent system was implanted in a pre-dilated severely calcified lesion (100 percent stenosis degree) in the moderately tortuous rca.After the intervention the patients condition became worse.During additional angiography it was noticed that the complaint stent was occluded.Aspiration was done but could not eliminate all occlusion, therefore another orsiro was implanted.
 
Manufacturer Narrative
Combination product: yes shortly after treating a prox.Rca lesion with a orsiro 3.0/30 des the patient status became worse.Examination revealed a stent thrombosis at the level of the implanted des.The treatment was finished with the successful placement of another orsiro des.The device itself was not returned to biotronik and could therefore not be subjected to a technical investigation.However, the provided report was reviewed.Further the production documentation of the product was reviewed to establish whether a deviation from the manufacturing process could be the cause for this event.Review of the production documentation for the product described above confirmed that the device was manufactured according to specifications and fulfilled all the requirements of in-process and final inspection.Based on the reviewed documentation and the conducted investigation no device deficiency or manufacturing related root cause could be identified.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ORSIRO 3.0/30
Type of Device
CORONARY DRUG-ELUTING STENT
Manufacturer (Section D)
BIOTRONIK AG, BUELACH, SWITZERLAND
ackerstrasse 6
buelach CH-81 80
CH  CH-8180
MDR Report Key11770526
MDR Text Key248830502
Report Number1028232-2021-02272
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)Y
PMA/PMN Number
P170030
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 05/04/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date04/17/2022
Device Model Number364514
Device Catalogue NumberSEE MODEL NO.
Device Lot Number03204057
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 05/04/2021
Initial Date FDA Received05/04/2021
Supplement Dates Manufacturer Received08/06/2021
Supplement Dates FDA Received08/06/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-